Loading organizations...
§ Private Profile · Surry Hills, New South Wales, Australia
Digital health platform connecting patients to clinical trials using AI and machine learning for faster treatment access.
HealthMatch is a digital health platform based in Surry Hills, Sydney, Australia, that utilizes AI and machine learning to connect patients with suitable clinical trials in real-time based on their medical profiles. The company has raised $25 million in total funding, including an $18 million Series B round in 2020, and was valued at $90 million as of its last profile date. Its platform has accumulated over 120,000 patient profiles, with 11,000 individuals successfully placed into trials by 2021, and operates with an employee count ranging from 21 to 50. Notable investors include Square Peg Capital, which led its Series B funding round. HealthMatch aims to accelerate patient recruitment for pharmaceutical companies and medical researchers while expanding access to emerging treatments for patients. It was founded in 2017 by Manuri Gunawardena.
HealthMatch has raised $26.0M across 3 funding rounds.
HealthMatch has raised $26.0M in total across 3 funding rounds.
HealthMatch is a digital health technology company that builds an AI-powered platform connecting patients with clinical trials by matching their medical profiles to suitable studies, accelerating medical research and improving access to innovative treatments.[1][2][3][7] It serves patients seeking trials, clinical trial sponsors (pharmaceutical companies, universities, government agencies), and researchers by simplifying eligibility checks, applications, and recruitment, solving key challenges like slow patient enrollment and limited doctor awareness of trials.[1][2][3] The platform has matched over 2 million patient profiles across more than 300 conditions in four countries, placed 36,000+ patients in trials (with earlier figures at 11,000 in two years), and raised $25 million in venture funding, demonstrating strong growth momentum.[2][3][7]
HealthMatch was founded in 2017 in Surry Hills (Sydney), Australia, by Manuri Gunawardena, who launched it after her medical school experience in neuro-oncology research on Glioblastoma multiforme (GBM), an aggressive brain cancer.[1][2][3] Witnessing firsthand the difficulties researchers faced in finding suitable patients and patients' reliance on doctors for trial information, Gunawardena created the platform to empower patients directly.[3] Officially launched in 2019, it quickly gained traction, raising $25 million from investors in Australia, the US, and Singapore—including Australia's largest local health tech funding round in 2020—and helping 120,000 patients create profiles within two years, leading to 11,000 trial placements.[3]
HealthMatch rides the clinical trials tech trend of AI-optimized recruitment, addressing a market bottleneck where 85% of trials fail to meet enrollment timelines due to inefficient patient finding.[1] Its timing aligns with rising demand for decentralized trials, EHR integrations, and patient empowerment post-COVID, fueled by pharma's push for faster drug development amid $2.6B average trial costs.[1][2] Market forces like AI advancements in NLP/ML for unstructured data and regulatory support for digital health favor it, positioning HealthMatch as an "Outperformer" in CB Insights' landscape with 13 peers.[1] It influences the ecosystem by democratizing access—bypassing doctor gatekeepers—boosting trial diversity/speed and enabling sponsors to tap global patient pools efficiently.[2][3]
HealthMatch is poised to expand its 2+ million user base and trial placements through deeper AI refinements, international scaling (beyond US/Australia focus), and partnerships with more pharma giants, leveraging its HIPAA stack for compliant growth.[2][7] Trends like federated learning for privacy-preserving data and real-world evidence integration will shape its path, potentially capturing share in the $50B+ clinical trials market.[1] Its influence may evolve from recruitment matcher to full trial orchestration platform, further accelerating therapies for rare diseases—echoing its origins in bridging patient desperation with research breakthroughs.[3]
HealthMatch has raised $26.0M across 3 funding rounds. Most recently, it raised $7.0M Series C in September 2022.
HealthMatch has raised $26.0M in total across 3 funding rounds.
HealthMatch's investors include Blackbird Ventures Australia, Bond, CITG Capital, E1 Ventures, Footwork, FPV Fund, Heartcore Capital, InterWest, Jigsaw VC, Partech Ventures, Sapphire Ventures, Shasta Ventures.